MDMA Effects in Brain: Pharmacologic Profile and Evidence of Neurotoxicity from Neurochemical and Autoradiographic Studies
- 1 January 1990
- book chapter
- Published by Springer Nature
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicityJournal of Neuroscience, 1988
- Pharmacologic profile of MDMA (3,4-methylenedioxymethamphetamine) at various brain recognition sitesEuropean Journal of Pharmacology, 1988
- New Data Intensify the Agony Over EcstasyScience, 1988
- MDMA-induced neurotoxicity: Parameters of degeneration and recovery of brain serotonin neuronsPharmacology Biochemistry and Behavior, 1988
- Self-injection of d,1-3,4-methylenedioxymethamphetamine (MDMA) in the baboonPsychopharmacology, 1987
- The Background and Chemistry of MDMAJournal of Psychoactive Drugs, 1986
- The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) on monoaminergic systems in the rat brainEuropean Journal of Pharmacology, 1986
- Hallucinogenic Amphetamine Selectively Destroys Brain Serotonin Nerve TerminalsScience, 1985
- 5-HT1 and 5-HT2 binding properties of derivatives of the hallucinugen 1-(2,5-dimethoxyphenyl)-2-aminopropane (2,5-DMA)European Journal of Pharmacology, 1984
- LIGAND: A versatile computerized approach for characterization of ligand-binding systemsAnalytical Biochemistry, 1980